Immune reconstitution following hematopoietic stem-cell transplantation

Best Practice and Research: Clinical Haematology

Volumn 20, Issue 2, 2007, Pages 329-348

  Geddes, Michelle ^a   Storek, Jan ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

allogeneic transplantation; antibody formation; autologous transplantation; hematopoietic stem cell transplantation; immune system; lymphocytes

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ANTIBIOTIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENT; COTRIMOXAZOLE; CYTOKINE; DIPHTHERIA TETANUS VACCINE; GRANULOCYTE COLONY STIMULATING FACTOR; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR; MEASLES MUMPS RUBELLA VACCINE; PALIFERMIN; PENICILLIN G; PLACEBO; PNEUMOCOCCUS VACCINE;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; B LYMPHOCYTE; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CHICKENPOX; CLINICAL TRIAL; CLOSTRIDIUM TETANI; CORYNEBACTERIUM DIPHTHERIAE; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DIPHTHERIA; DISEASE ASSOCIATION; DONOR LYMPHOCYTE INFUSION; EPITHELIUM; FOOD HANDLING; GRAFT INFECTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HAEMOPHILUS INFLUENZAE; HAND WASHING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION RESISTANCE; INFECTION SENSITIVITY; INFLUENZA; INNATE IMMUNITY; LYMPHOCYTE COUNT; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; MEASLES; MEASLES VIRUS; MONOCYTE; MUCOSA INFLAMMATION; MUMPS; MUMPS VIRUS; MYELOABLATIVE CONDITIONING; NATURAL KILLER CELL; NEUTROPHIL; NONMYELOABLATIVE CONDITIONING; PERSONAL HYGIENE; PHAGOCYTE; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RECURRENT INFECTION; REDUCED INTENSITY CONDITIONING; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TETANUS; THYMUS FUNCTION; VARICELLA ZOSTER VIRUS;

ANTIBODY FORMATION; B-LYMPHOCYTES; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CROSS INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; IMMUNOGLOBULINS, INTRAVENOUS; LEUKOCYTES; LYMPHOCYTE COUNT; PATIENT ISOLATION; T-LYMPHOCYTES; VACCINATION;

EID: 34247146343     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2006.09.009     Document Type: Review

References (117)

1. Chung B., Barbara-Burnham L., Barsky L., et al. Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood 98 5 (2001) 1601-1606
2. Atkinson K., Farewell V., Storb R., et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 60 3 (1982) 714-720
3. Small T.N., Papadopoulos E.B., Boulad F., et al. Comparison of Immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 93 2 (1999) 467-480
4. Storek J., Viganego F., Dawson M.A., et al. Factors affecting antibody levels after allogeneic hematopoietic cell transplantation. Blood 101 8 (2003) 3319-3324
5. Marshall N.A., Howe J.G., Formica R., et al. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood 96 8 (2000) 2814-2821
6. Porrata L.F., Litzow M.R., Inwards D.J., et al. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplantation 33 3 (2004) 291-298
7. Savani B.N., Rezvani K., Mielke S., et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 107 4 (2006) 1688-1695
8. Storek J., Espino G., Dawson M.A., et al. Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation. Blood 96 9 (2000) 3290-3293
9. Kim D.H., Sohn S.K., Won D.I., et al. Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplantation 37 12 (2006) 1119-1128
10. Novitzky N., Davison G.M., Hale G., et al. Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome. Transplantation 74 11 (2002) 1551-1559
11. Boeckh M., Nakamura R., Cornelissen J.J., et al. Immune monitoring with iTAg(TM) MHC tetramers for prediction of recurrent or persistent cytomegalovirus (CMV) infection in allogeneic stem cell transplant (SCT) recipients: a prospective multicenter clinical trial. Biology of Blood and Marrow Transplantation 12 2, supplement 1 (2006) 79
12. Krause H., Hebart H., Jahn G., et al. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplantation 19 11 (1997) 1111-1116
13. Baron F., Baker J.E., Storb R., et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 104 8 (2004) 2254-2262
14. Yeh C.K., Dodds M.W., Zuo P., et al. A population-based study of salivary lysozyme concentrations and candidal counts. Archives of Oral Biology 42 1 (1997) 25-31
15. Chaushu G., Itzkovitz-Chaushu S., Yefenof E., et al. A longitudinal follow-up of salivary secretion in bone marrow transplant patients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 79 2 (1995) 164-169
16. Alper C.A., Johnson A.M., Birtch A.G., et al. Human C prime 3: evidence for the liver as the primary site of synthesis. Science 163 3864 (1969) 286-288
17. Naughton M.A., Botto M., Carter M.J., et al. Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. Journal of Immunology (Baltimore, Md.) 156 8 (1996) 3051-3056
18. Mullighan C.G., Heatley S., Doherty K., et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 99 10 (2002) 3524-3529
19. Westerhuis G., Maas W.G.E., Willemze R., et al. Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance. Blood 106 6 (2005) 2215-2220
20. Lee L.A., Sergio J.J., and Sykes M. Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells. Transplantation 61 1 (1996) 125-132
21. Storek J., Dawson M.A., Storer B., et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97 11 (2001) 3380-3389
22. Przepiorka D., Smith T.L., Folloder J., et al. Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors. Blood 97 11 (2001) 3405-3410
23. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. The New England Journal of Medicine 351 22 (2004) 2265-2275
24. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. The New England Journal of Medicine 351 22 (2004) 2276-2285
25. Franzke A., Piao W., Lauber J., et al. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 102 2 (2003) 734-739
26. Volpi I., Perruccio K., Tosti A., et al. Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. Blood 97 8 (2001) 2514-2521
27. Ho V.T., Mirza N.Q., del Junco D., et al. The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis. Bone Marrow Transplantation 32 8 (2003) 771-775
28. Khoury H.J., Loberiza Jr. F.R., Ringden O., et al. Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. Blood 107 4 (2006) 1712-1716
29. Sosa R., Weiden P.L., Storb R., et al. Granulocyte function in human allogenic marrow graft recipients. Experimental Hematology 8 10 (1980) 1183-1189
30. Zimmerli W., Zarth A., Gratwohl A., et al. Neutrophil function and pyogenic infections in bone marrow transplant recipients. Blood 77 2 (1991) 393-399
31. Walsh L.J., Athanasas-Platsis S., and Savage N.W. Reconstitution of cutaneous neural-immunological networks following bone marrow transplantation. Transplantation 61 3 (1996) 413-417
32. Perreault C., Pelletier M., Landry D., et al. Study of Langerhans cells after allogeneic bone marrow transplantation. Blood 63 4 (1984) 807-811
33. Fearnley D.B., Whyte L.F., Carnoutsos S.A., et al. Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. Blood 93 2 (1999) 728-736
34. Klangsinsirikul P., Carter G.I., Byrne J.L., et al. Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution. Blood 99 7 (2002) 2586-2591
35. Sale G.E., Alavaikko M., Schaefers K.M., et al. Abnormal CD4:CD8 ratios and delayed germinal center reconstitution in lymph nodes of human graft recipients with graft-versus-host disease (GVHD): an immunohistological study. Experimental Hematology 20 8 (1992) 1017-1021
36. Winston D.J., Territo M.C., Ho W.G., et al. Alveolar macrophage dysfunction in human bone marrow transplant recipients. The American Journal of Medicine 73 6 (1982) 859-866
37. Pechumer H., Leinisch E., Bender-Gotze C., et al. Recovery of monocytes after bone marrow transplantation-rapid reappearance of tumor necrosis factor alpha and interleukin 6 production. Transplantation 52 4 (1991) 698-704
38. Castenskiold E.C., Kelsey S.M., Collins P.W., et al. Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse. Bone Marrow Transplantation 15 6 (1995) 879-884
39. Tsoi M.S., Dobbs S., Brkic S., et al. Cellular interactions in marrow-grafted patients. II. Normal monocyte antigen-presenting and defective T-cell-proliferative functions early after grafting and during chronic graft-versus-host disease. Transplantation 37 6 (1984) 556-561
40. Roberts M.M., To L.B., Gillis D., et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplantation 12 5 (1993) 469-475
41. Ottinger H.D., Beelen D.W., Scheulen B., et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88 7 (1996) 2775-2779
42. Chen L., Cohen A.C., and Lewis D.B. Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells. Biology of Blood and Marrow Transplantation 12 2 (2006) 160-171
43. Szabolcs P., Park K.D., Reese M., et al. Coexistent naive phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Experimental Hematology 31 8 (2003) 708-714
44. Atkinson K., Hansen J.A., Storb R., et al. T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood 59 6 (1982) 1292-1298
45. Maris M., Boeckh M., Storer B., et al. Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. Experimental Hematology 31 10 (2003) 941-952
46. Storek J., Joseph A., Espino G., et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 98 13 (2001) 3505-3512
47. Roux E., Helg C., Chapuis B., et al. T-cell repertoire complexity after allogeneic bone marrow transplantation. Human Immunology 48 1-2 (1996) 135-138
48. Roux E., Helg C., Dumont-Girard F., et al. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 87 9 (1996) 3984-3992
49. Janossy G., Prentice H.G., Grob J.P., et al. T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow. Clinical and Experimental Immunology 63 3 (1986) 577-586
50. Tayebi H., Tiberghien P., Ferrand C., et al. Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation. Bone Marrow Transplantation 27 2 (2001) 167-175
51. Reusser P., Riddell S.R., Meyers J.D., et al. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78 5 (1991) 1373-1380
52. Storek J., Witherspoon R.P., Maloney D.G., et al. Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow. Blood 89 10 (1997) 3891-3892
53. Couban S., Simpson D.R., Barnett M.J., et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 100 5 (2002) 1525-1531
54. Storek J., Dawson M.A., and Maloney D.G. Correlation between the numbers of naive T cells infused with blood stem cell allografts and the counts of naive T cells after transplantation. Biology of Blood and Marrow Transplantation 9 12 (2003) 781-784
55. Storek J., Joseph A., Dawson M.A., et al. Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation. Transplantation 73 7 (2002) 1154-1158
56. Weinberg K., Blazar B.R., Wagner J.E., et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97 5 (2001) 1458-1466
57. Storek J., Zhao Z., Lin E., et al. Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases). Clinical Immunology (Orlando, Fla.) 113 3 (2004) 285-298
58. Storek J & Witherspoon RP. Immune reconstitution. In Atkinson K, et al (eds.) Clinical Bone Marrow and Blood Stem Cell Transplantation, 3rd edn. Cambridge University Press, pp. 194-226.
59. Storek J., Ferrara S., Rodriguez C., et al. Recovery of mononuclear cell subsets after bone marrow transplantation: overabundance of CD4+CD8+ dual-positive T cells reminiscent of ontogeny. Journal of Hematotherapy 1 4 (1992) 303-316
60. Bengtsson M., Totterman T.H., Smedmyr B., et al. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis. Leukemia 3 1 (1989) 68-75
61. Gorla R., Airo P., Ferremi-Leali P., et al. Predominance of 'memory' phenotype within CD4+ and CD8+ lymphocyte subsets after allogeneic BMT. Bone Marrow Transplantation 11 4 (1993) 346-347
62. Sugita K., Soiffer R.J., Murray C., et al. The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation. Transplantation 57 10 (1994) 1465-1473
63. Storek J., Witherspoon R.P., and Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplantation 16 3 (1995) 413-425
64. Weinberg K., Annett G., Kashyap A., et al. The effect of thymic function on immunocompetence following bone marrow transplantation. Biology of Blood and Marrow Transplantation 1 1 (1995) 18-23
65. O'Keefe C.L., Sobecks R.M., Wlodarski M., et al. Molecular TCR diagnostics can be used to identify shared clonotypes after allogeneic hematopoietic stem cell transplantation. Experimental Hematology 32 10 (2004) 1010-1022
66. Machatschek J., Duda J., Matthay K., et al. Immune reconstitution, infectious complications and post transplant supportive care measures after autologous blood and marrow transplantation in children. Bone Marrow Transplantation 32 7 (2003) 687-693
67. Jimenez M., Martinez C., Ercilla G., et al. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation. Experimental Hematology 33 10 (2005) 1240-1248
68. Douek D.C., McFarland R.D., Keiser P.H., et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 396 6712 (1998) 690-695
69. Klingemann H.G., Lum L.G., and Storb R. Phenotypical and functional studies on a subtype of suppressor cells (CD8+/CD11+) in patients after bone marrow transplantation. Transplantation 44 3 (1987) 381-386
70. Quinnan Jr. G.V., Kirmani N., Rook A.H., et al. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. The New England Journal of Medicine 307 1 (1982) 7-13
71. Gratama J.W., van Esser J.W., Lamers C.H., et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 98 5 (2001) 1358-1364
72. Kook H., Goldman F., Padley D., et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 88 3 (1996) 1089-1097
73. Locatelli F., Maccario R., Comoli P., et al. Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children. Bone Marrow Transplantation 18 6 (1996) 1095-1101
74. van Tol M.J., Gerritsen E.J., de Lange G.G., et al. The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation. Blood 87 2 (1996) 818-826
75. Lum L.G., Munn N.A., Schanfield M.S., et al. The detection of specific antibody formation to recall antigens after human bone marrow transplantation. Blood 67 3 (1986) 582-587
76. Storek J., Witherspoon R.P., and Storb R. Reconstitution of membrane IgD- (mIgD-) B cells after marrow transplantation lags behind the reconstitution of mIgD+ B cells. Blood 89 1 (1997) 350-351
77. Storek J., Ferrara S., Ku N., et al. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?. Bone Marrow Transplantation 12 4 (1993) 387-398
78. Suzuki I., Milner E.C., Glas A.M., et al. Immunoglobulin heavy chain variable region gene usage in bone marrow transplant recipients: lack of somatic mutation indicates a maturational arrest. Blood 87 5 (1996) 1873-1880
79. Sullivan K.M., Storek J., Kopecky K.J., et al. A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. Biology of Blood and Marrow Transplantation 2 1 (1996) 44-53
80. Gerritsen E.J., van Tol M.J., Ballieux P., et al. Search for the antigen-specificity of homogeneous IgG components (H-IgG) after allogeneic bone marrow transplantation. Bone Marrow Transplantation 17 5 (1996) 825-833
81. Hallstrand T.S., Sprenger J.D., Agosti J.M., et al. Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors. Blood 104 10 (2004) 3086-3090
82. Shalit M., Amar A., and Or R. Allergy development after bone marrow transplantation from a non-atopic donor. Clinical and Experimental Allergy 32 12 (2002) 1699-1701
83. Marazuela M., and Steegman J.L. Transfer of autoimmune hypothyroidism following bone marrow transplantation from a donor with Graves' disease. Bone Marrow Transplantation 26 11 (2000) 1217-1220
84. Kostova G., Heim D., Passweg J., et al. Cytopenia and hematopoietic recovery after low intensity conditioning transplants. Croatian Medical Journal 45 4 (2004) 445-450
85. Daly A., McAfee S., Dey B., et al. Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants. Biology of Blood and Marrow Transplantation 9 6 (2003) 373-382
86. Chalandon Y., Degermann S., Villard J., et al. Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. Blood 107 1 (2006) 389-396
87. Chakrabarti S., Mackinnon S., Chopra R., et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 99 12 (2002) 4357-4363
88. Mohty M., Faucher C., Vey N., et al. High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation. Bone Marrow Transplantation 26 3 (2000) 251-255
89. Manteiga R., Martino R., Sureda A., et al. Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience. Bone Marrow Transplantation 22 9 (1998) 899-904
90. Perdelli F., Sartini M., Spagnolo A.M., et al. A problem of hospital hygiene: The presence of aspergilli in hospital wards with different air-conditioning features. American Journal of Infection Control 34 5 (2006) 264-268
91. Alberti C., Bouakline A., Ribaud P., et al. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. The Journal of Hospital Infection 48 3 (2001) 198-206
92. Moody K., Finlay J., Mancuso C., et al. Feasibility and safety of a pilot randomized trial of infection rate: neutropenic diet versus standard food safety guidelines. Journal of Pediatric Hematology/Oncology 28 3 (2006) 126-133
93. Rhame F.S., Streifel A.J., Kersey J.J.H., et al. Extrinsic risk factors for pneumonia in the patient at high risk of infection. The American Journal of Medicine 76 5 Part 1 (2000) 42-52
94. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biology of Blood and Marrow Transplantation 6 6a (2000) 659-713 5; 7-27
95. Spielberger R., Stiff P., Bensinger W., et al. Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers. The New England Journal of Medicine 351 25 (2004) 2590-2598
96. Alpdogan O., Hubbard V.M., Smith O.M., et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 107 6 (2006) 2453-2460
97. Panoskaltsis-Mortari A., Taylor P.A., Rubin J.S., et al. Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury. Blood 96 13 (2000) 4350-4356
98. Rossi S., Blazar B.R., Farrell C.L., et al. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood 100 2 (2002) 682-691
99. Ringden O., Labopin M., Gorin N.C., et al. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology 22 3 (2004) 416-423
100. Steer C.B., Szer J., Sasadeusz J., et al. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir. Bone Marrow Transplantation 25 6 (2000) 657-664
101. Epstein J.B., Ransier A., Sherlock C.H., et al. Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation. European Journal of Cancer. Part B, Oral Oncology 32B 3 (1996) 158-162
102. Morfin F., Bilger K., Boucher A., et al. HSV excretion after bone marrow transplantation: a 4-year survey. Journal of Clinical Virology 30 4 (2004) 341-345
103. Tuan I.Z., Dennison D., and Weisdorf D.J. Pneumocystis carinii pneumonitis following bone marrow transplantation. Bone Marrow Transplantation 10 3 (1992) 267-272
104. Marras T.K., Sanders K., Lipton J.H., et al. Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation. Transplant Infectious Disease 4 2 (2002) 66-74
105. Storek J., Dawson M.A., Lim L.C., et al. Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation. Bone Marrow Transplantation 33 3 (2004) 337-346
106. Ljungman P., Engelhard D., de la Camara R., et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplantation 35 8 (2005) 737-746
107. Emanuel D., Cunningham I., Jules-Elysee K., et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Annals of Internal Medicine 109 10 (1988) 777-782
108. Reed E.C., Bowden R.A., Dandliker P.S., et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Annals of Internal Medicine 109 10 (1988) 783-788
109. A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol. MMWR. Morbidity and Mortality Weekly Report 55 8 (2006) 209-210
110. Papadopoulos E.B., Ladanyi M., Emanuel D., et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. The New England Journal of Medicine 330 17 (1994) 1185-1191
111. Bollard C.M., Kuehnle I., Leen A., et al. Adoptive immunotherapy for posttransplantation viral infections. Biology of Blood and Marrow Transplantation 10 3 (2004) 143-155
112. Hromas R., Cornetta K., Srour E., et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 84 5 (1994) 1689-1690
113. Ramadan G., Davies B., Kurup V.P., et al. Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen. Clinical and Experimental Immunology 140 1 (2005) 81-91
114. Alpdogan O., Schmaltz C., Muriglan S.J., et al. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98 7 (2001) 2256-2265
115. Lu H., Zhao Z., Kalina T., et al. Interleukin-7 improves reconstitution of antiviral CD4 T cells. Clinical Immunology (Orlando, Fla.) 114 1 (2005) 30-41
116. Sinha M.L., Fry T.J., Fowler D.H., et al. Interleukin 7 worsens graft-versus-host disease. Blood 100 7 (2002) 2642-2649
117. Kalina T., Lu H., Zhao Z., et al. De novo generation of CD4 T cells against viruses present in the host during immune reconstitution. Blood 105 6 (2005) 2410-2414